- 201. Logical Observation Identifiers Names and Codes
- [Published by the The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI) ( NCI )] (UMLS (NCI) C1136323) LOINC =Intellectual Product
| - 251. LONGITUDINAL DEFIC FEMUR
- [ ] (UMLS (ICD9CM) C0158755) =Congenital Abnormality
|
- 202. Logiparin
- (UMLS (NCI) C0212081) =Carbohydrate ;
| - 252. LONGITUDINAL DEFIC FOOT
- [ ] (UMLS (ICD9CM) C0158759) =Congenital Abnormality ;
|
- 203. logo
- [FDA label logo ( HL7V3.0 )] (UMLS (HL7) C1552082) =Intellectual Product =FDALabelData;
| - 253. LONGITUDINAL DEFIC HAND
- [ ] (UMLS (ICD9CM) C0158748) =Congenital Abnormality
|
- 204. LOH
- [genetic phenomenon due to deletion or mutation in one allele of a polymorphic gene, as detected by expression after cell fusion; used as a test for tumor-promoting mutations; do not confuse with "loss of heterogeneity" which applies to diverse cell populations within a tissue. ( CSP )] (UMLS (NCI) C0524869) =Genetic Function; Cell or Molecular Dysfunction =Chromosomal Deletion;
DNA Alteration;
neoplasm/cancer diagnosis;
| - 254. LONGITUDINAL DEFIC TIBIA
- [ ] (UMLS (ICD9CM) C0158757) =Congenital Abnormality ;
|
- 205. LOH11CR2A
- [This gene may play a role in the negative regulation of cell growth. ( NCI )] (UMLS (NCI) C1334348) LOH11CR2A Gene;
Loss of Heterozygosity, 11, Chromosomal Region 2, Gene A Gene =Gene or Genome ;
| - 255. LONGITUDINAL DEFIC ULNA
- [ ] (UMLS (ICD9CM) C0158747) =Congenital Abnormality
|
- 206. LOIASIS
- [A parasitic infection caused by the nematode Loa loa. The vector in the transmission of this infection is the horsefly (Tabanus) or the deerfly or mango fly (Chrysops). The larvae may be seen just beneath the skin or passing through the conjunctiva. Eye lesions are not uncommon. The disease is generally mild and painless. ( MSH )] (UMLS (ICD9CM) C0023968) =Disease or Syndrome ;
=filariasis;
| - 256. Longitudinal deficiency, tibiofibular, complete or partial (with or without distal deficiencies, incomplete)
- [ ] (UMLS (ICD9CM) C0158756) =Congenital Abnormality
|
- 207. LOINC Axis 4
- [A group of independent but interrelated elements comprising a unified whole. ( NCI )] (UMLS (NCI) C0449913) =Functional Concept ;
| - 257. Longitudinal Fissure
- (UMLS (NCI) C0228186) =Body Part, Organ, or Organ Component
|
- 208. LOINC Axis 6
- [The process by which an observation value was obtained. Example methods include: weighing, use of a mass spectrometer, use of an ion sensitive electrode, and examination using a microscope. ( NCI )] (UMLS (NCI) C0025664) =Intellectual Product
| - 258. longitudinal human study
- [studies following a population of humans over a period of time; it includes retrospective studies analyzing characteristics such as dietary and health habits, disease history, environment, and other factors culminating in present health status; study may use any combination of human subjects, data, tissues, etc. ( CSP )] (UMLS (CSP) C0596860) =Intellectual Product =human population study;
|
- 209. Loligo
- [A genus of SQUID in the family Loliginidae, superorder DECAPODIFORMES, with a spindle-shaped body. They are well-studied, common inshore squids of the Atlantic and eastern Pacific Oceans, but their various species are taxonomically unresolved. ( MSH )] (UMLS (CSP) C0599467) =Invertebrate
| - 259. longitudinal positron emission tomography
- [ ] (UMLS (CSP) C0596861) =Diagnostic Procedure
|
- 210. Lomefloxacin
- [A synthetic broad-spectrum fluoroquinolone with antibacterial activity. Lomefloxacin inhibits DNA gyrase, a type II topoisomerase involved in the induction or relaxation of supercoiling during DNA replication. This inhibition leads to a decrease in DNA synthesis during bacterial replication, resulting in cell growth inhibition and eventually cell lysis. ( NCI )] (UMLS (NCI) C0065162) =Organic Chemical; Pharmacologic Substance ;
=Quinolones;
[AM900] ANTI-INFECTIVES, OTHER =(+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, monohydrochloride;
| - 260. Longitudinal Study
- [In medicine, a study or clinical trial in which participants are identified and then followed forward in time. ( NCI )] (UMLS (NCI) C0023981) =Research Activity ;
|
- 211. LOMERIZINE
- (UMLS (NCI) C0630704) =Organic Chemical; Pharmacologic Substance
| - 261. Longus Capitis
- (UMLS (NCI) C0224107) =Body Part, Organ, or Organ Component
|
- 212. Lomifylline
- (UMLS (NCI) C0614278) =Pharmacologic Substance
| - 262. Longus Colli
- (UMLS (NCI) C0224169) =Body Part, Organ, or Organ Component
|
- 213. Lomir
- (UMLS (NCI) C0733558) =Organic Chemical; Pharmacologic Substance ;
| - 263. Loniten
- (UMLS (NCI) C0699464) =Organic Chemical; Pharmacologic Substance
|
- 214. Lomustine/Procarbazine
- (UMLS (NCI) C0796683) =Therapeutic or Preventive Procedure
| - 264. Lonomycin
- (UMLS (NCI) C0065176) =Organic Chemical; Pharmacologic Substance ;
|
- 215. Lomustine/Temozolomide
- (UMLS (NCI) C0879573) =Therapeutic or Preventive Procedure
| - 265. Loop, Ishial
- (UMLS (HL7) C1550268) =Body Part, Organ, or Organ Component =Body Part;
|
- 216. Lomustine/Temozolomide/Thalidomide
- (UMLS (NCI) C1328083) =Therapeutic or Preventive Procedure ;
| - 266. Loose body in ankle and foot joint
- [ ] (UMLS (ICD9CM) C0158087) =Disease or Syndrome; Anatomical Abnormality
|
- 217. Lonafarnib/Paclitaxel/Trastuzumab
- (UMLS (NCI) C1328038) =Therapeutic or Preventive Procedure ;
| - 267. Loose body in forearm joint
- [ ] (UMLS (ICD9CM) C0158084) =Acquired Abnormality; Disease or Syndrome
|
- 218. Lonazolac
- (UMLS (NCI) C0065166) =Organic Chemical; Pharmacologic Substance ;
| - 268. Loose body in hand joint
- [ ] (UMLS (ICD9CM) C0158085) =Acquired Abnormality; Disease or Syndrome
|
- 219. Loneliness
- [The state of feeling sad or dejected as a result of lack of companionship or being separated from others. ( MSH )] (UMLS (NCI) C0023974) =Mental Process ;
| - 269. Loose body in joint of multiple sites
- [ ] (UMLS (ICD9CM) C0158088) =Acquired Abnormality; Disease or Syndrome
|
- 220. Long
- [Of relatively great or greater than average spatial extension or temporal duration. ( NCI )] (UMLS (NCI) C0205166) =Qualitative Concept
| - 270. Loose body in joint of other specified sites
- (UMLS (ICD9CM) C0023988) =Acquired Abnormality ;
|
- 221. Long Bone
- (UMLS (NCI) C0222647) =Body Part, Organ, or Organ Component
| - 271. Loose body in joint of pelvic region and thigh
- [ ] (UMLS (ICD9CM) C0158086) =Acquired Abnormality; Disease or Syndrome
|
- 222. Long Bone Metaphysis
- [Subdivision of diaphysis which forms the proximal or distal end of diaphysis next to the epiphysis; together with diaphysis proper, it constitutes the diaphysis. Examples: proximal metaphysis of humerus, distal metaphysis of femur. ( UWDA )] (UMLS (NCI) C0222671) =Body Part, Organ, or Organ Component
| - 272. Loose body in joint of shoulder region
- [ ] (UMLS (ICD9CM) C0158082) =Acquired Abnormality; Disease or Syndrome
|
- 223. long chain fatty acid
- [fatty acid components of structurally important lipids, as opposed to short chain fatty acids of intermediary metabolism; arbitrarily defined as those with 10 or more carbon atoms. ( CSP )] (UMLS (CSP) C0522095) =Lipid; Biologically Active Substance ;
=Fatty Acid;
=palmitate;
stearate;
linoleate;
linolenate;
myristate;
oleate;
| - 273. LOOSE BODY IN KNEE
- [ ] (UMLS (ICD9CM) C0343161) =Acquired Abnormality
|
- 224. long hunderdweight (British)
- [112 [lb_av] ( HL7V3.0 )] (UMLS (HL7) C1552953) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 274. Loose body in upper arm joint
- [ ] (UMLS (ICD9CM) C0158083) =Acquired Abnormality; Disease or Syndrome
|
- 225. Long labor
- (UMLS (ICD9CM) C0152154) =Pathologic Function
| - 275. Loose Connective Tissue
- [Irregular connective tissue, the intercellular matrix of which contains a sparse irregular network of collagen and elastic fiber bundles. ( NCI )] (UMLS (NCI) C1253917) =Tissue ;
|
- 226. LONG QT SYNDROME
- [prolongation of Q-T interval combined with torsades de pointes and manifests as several different forms; may be acquired or congenital; may lead to serious arrhythmia and sudden cardiac death. ( CSP )] (UMLS (ICD9CM) C0023976) =Disease or Syndrome ;
=Heart Rate, Increased;
| - 276. LOPERAMIDE
- [A synthetic agent chemically related to the opiates with anti-diarrheal properties. Loperamide decreases gastro-intestinal motility by effects on the circular and longitudinal muscles of the intestine. Part of its anti-diarrheal effect may be due to a reduction of gastro-intestinal secretion produced by opioid receptor binding in the intestinal mucosa. (NCI04) ( NCI )] (UMLS (NCI) C0023992) =Organic Chemical; Pharmacologic Substance =[GA400] ANTIDIARRHEAL AGENTS;
Piperidines =LOPERAMIDE HYDROCHLORIDE |
- 227. Long Term
- [Involving or being in effect for a long time. ( NCI )] (UMLS (NCI) C0443252) =Temporal Concept
| - 277. lopid
- [ ] (UMLS (CSP) C0700003) =Lipid; Pharmacologic Substance ;
|
- 228. Long Term Care
- (UMLS (HL7) C1547194) =Health Care Related Organization =Organization Unit Type;
| - 278. Lopinavir
- [A protease inhibitor used against human immunodeficiency virus (HIV). Lopinavir competitively inhibits the HIV-1 protease, an enzyme that mediates the cleavage of Gag, Gag-Pol and Nef precursor polypeptides into their mature proteins, including protease, reverse transcriptase, and integrase. Inhibition of HIV-1 protease prevents cleavage of the viral polyprotein precursor and results in the release of immature, noninfectious virions. ( NCI )] (UMLS (NCI) C0674432) =Organic Chemical; Pharmacologic Substance =[AM800] ANTIVIRALS;
protease inhibitor;
Unclassified Ingredients;
=lopinavir 133 MG;
LOPINAVIR 400 MG/5ML |
- 229. long term hospitalization
- [ ] (UMLS (CSP) C0598609) =Health Care Activity
| - 279. Lopinavir/Ritonavir
- [A combination anti-HIV protease inhibitor from Abbott Laboratories. Brand name is Kaletra. ( NCI )] (UMLS (NCI) C0939237) RITONAVIR/LOPINAVIR UNIDENTIFIED =Organic Chemical; Pharmacologic Substance ;
|
- 230. long term memory
- [memory that is retained over a long period of time; thought to be accompanied by structural alterations on two levels of synaptic organization, 1) a change in the number, size and vesicle component of synapse active zones, and 2) a modulation of the total number of synaptic varicosities. ( CSP )] (UMLS (CSP) C0423909) =Mental Process =memory;
| - 280. LOPRAZOLAM
- (UMLS (NCI) C0077013) =Organic Chemical; Pharmacologic Substance ;
|
- 231. long term potentiation
- [calcium dependent change in synaptic efficacy that is thought to mediate the memory consolidation function of the brain; induction phase lasts 30-60 minutes and involves NMDA receptors, maintenance phase last 2-3 hours. ( CSP )] (UMLS (CSP) C0206249) =Organ or Tissue Function ;
=membrane potential;
neural plasticity | - 281. Lopressor
- (UMLS (NCI) C0700776) =Organic Chemical; Pharmacologic Substance
|
- 232. Long Term Survivor
- [person surviving past expected longevity for a particular disease. ( CSP )] (UMLS (NCI) C0206193) =Patient or Disabled Group ;
=human mortality;
| - 282. Lopurin
- (UMLS (NCI) C0701099) =Organic Chemical; Pharmacologic Substance ;
|
- 233. Long Terminal Repeat
- [Identical DNA sequences found at either end of retrovirus proviral DNA, formed by reverse transcription of viral RNA. ( NCI )] (UMLS (NCI) C0023978) =Nucleic Acid, Nucleoside, or Nucleotide ;
| - 283. LORATADINE
- [A piperidine histamine H1-receptor antagonist with anti-allergic properties and without sedative effects. Loratadine blocks the H1 histamine receptor and prevents the symptoms that are caused by histamine activity on capillaries, bronchial smooth muscle, and gastrointestinal smooth muscle, including vasodilatation, increased capillary permeability, bronchoconstriction, and spasmodic contraction of gastrointestinal smooth muscle. Loratadine does not cross the blood-brain barrier and does not cause central nervous system effects. ( NCI )] (UMLS (NCI) C0065180) =Organic Chemical; Pharmacologic Substance ;
=cyproheptadine;
[AH900] ANTIHISTAMINES, OTHER =Loratadine 1 MG/ML;
LORATADINE 10 MG;
LORATADINE 5 MG;
|
- 234. long ton (British)
- [20 [lcwt_av] ( HL7V3.0 )] (UMLS (HL7) C1552955) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 284. lordosis
- [The anterior concavity in the curvature of the lumbar and cervical spine as viewed from the side. The term usually refers to abnormally increased curvature (hollow back, saddle back, swayback). It does not include lordosis as normal mating posture in certain animals ( = POSTURE + SEX BEHAVIOR, ANIMAL). ( MSH )] (UMLS (CSP) C0024003) =Anatomical Abnormality =Deficiency Diseases;
Curvature of spine |
- 235. Long Transient Receptor Potential Channel 5
- [Expressed in various tissues by human TRPM5 Gene, Transient Receptor Potential Cation Channel Subfamily M Member 5 is related to the transient receptor potential (trp) protein TRPC1 and potentially involved in regulation of cellular Ca(2+) influx. The putative open reading frame encodes alternative 872-aa or 1,165-aa proteins, each with several predicted membrane-spanning domains. Mouse Trpm5 functions as a cationic channel that is gated when internal calcium stores are depleted. (NCI) ( NCI )] (UMLS (NCI) C1334521) LTRPC5;
MLSN1 and TRP-Related Protein;
MTR1;
Transient Receptor Potential Cation Channel, Subfamily M, Member 5;
TRPM5 =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 285. lordosis
- [ ] (UMLS (CSP) C0599412) =Individual Behavior ;
|
- 236. Long-Term Care
- (UMLS (HL7) C1552238) =Professional or Occupational Group =Clinical Nurse Specialist;
| - 286. Lordosis (acquired)
- (UMLS (ICD9CM) C0024004) =Acquired Abnormality
|
- 237. Long-Term Screening
- (UMLS (NCI) C1134630) =Diagnostic Procedure ;
| - 287. Lordosis (acquired) (postural)
- (UMLS (ICD9CM) C0024005) =Acquired Abnormality
|
- 238. longevity
- [length of life. ( CSP )] (UMLS (CSP) C0023980) =Temporal Concept ;
=aging;
| - 288. Lordosis associated with other conditions
- [ ] (UMLS (ICD9CM) C0158508) =Disease or Syndrome; Anatomical Abnormality
|
- 239. Longissimus Capitis
- (UMLS (NCI) C0224309) =Body Part, Organ, or Organ Component
| - 289. LORDOSIS NEC
- [ ] (UMLS (ICD9CM) C0029658) =Acquired Abnormality ;
|
- 240. Longissimus Cervicis
- (UMLS (NCI) C0224308) =Body Part, Organ, or Organ Component
| - 290. Lordosis, postlaminectomy
- [ ] (UMLS (ICD9CM) C0158500) =Acquired Abnormality ;
|
- 241. Longissimus Thoracis
- (UMLS (NCI) C0224307) =Body Part, Organ, or Organ Component
| - 291. Loreclezole
- (UMLS (NCI) C0083257) =Organic Chemical; Pharmacologic Substance ;
|
- 242. LONGITUD DEFIC ARM NEC
- [ ] (UMLS (ICD9CM) C0375533) =Congenital Abnormality
| - 292. Lorenzo oil
- [combination of two fats extracted from olive oil and rapeseed oil, respectively; composed of glyceryl trierucate and glyceryl trioleate in 1:4 ratio; used to lower plasma levels of very long-chain fatty acids in patients with X-linked adrenoleukodystrophy. ( CSP )] (UMLS (CSP) C0212874) =Lipid; Pharmacologic Substance =plant extract;
VEGETABLE OIL |
- 243. LONGITUD DEFIC PHALANGES
- [ ] (UMLS (ICD9CM) C0490053) =Congenital Abnormality ◊ [ ] (UMLS (ICD9CM) C0490054) Congenital Abnormality
| - 293. loris
- [ ] (UMLS (CSP) C1265470) =Mammal
|
- 244. LONGITUD DEFIC RADIOULNA
- [ ] (UMLS (ICD9CM) C0158745) =Congenital Abnormality
| - 294. Lorisidae
- [A family of Primates of the suborder Strepsirhini containing six genera. The family is distributed in parts of Africa, India, Asia, and the Philippines. The six genera are: Arctocebus (golden potto), GALAGO (bush babies), Loris (slender loris), Nycticebus (slow loris), and Perodicticus (potto). Lorises and pottos are relatively common except for Arctocebus, the golden potto. All are arboreal and nocturnal. ( MSH )] (UMLS (CSP) C0024010) =Mammal
|
- 245. LONGITUD DEFIC RADIUS
- [ ] (UMLS (ICD9CM) C0158746) =Congenital Abnormality
| - 295. Loron
- (UMLS (NCI) C0591741) =Organophosphorus Compound; Pharmacologic Substance ;
|
- 246. LONGITUDIN DEFIC FIBULA
- [ ] (UMLS (ICD9CM) C0158758) =Congenital Abnormality ;
| - 296. Los Coyotes Band of Cahuilla Mission Indians of th
- (UMLS (HL7) C1554358) =Population Group =NativeEntityContiguous;
|
- 247. LONGITUDIN DEFIC HUMERUS
- [ ] (UMLS (ICD9CM) C0158744) =Congenital Abnormality
| - 297. Losoxantrone
- [An anticancer drug that belongs to the family of drugs called antipyrazoles. ( NCI )] (UMLS (NCI) C0245032) =Organic Chemical; Pharmacologic Substance ;
|
- 248. LONGITUDIN DEFIC LEG NEC
- [ ] (UMLS (ICD9CM) C0375534) =Anatomical Abnormality
| - 298. LOSS CONT MV ACC-ST CAR
- [ ] (UMLS (ICD9CM) C0261096) =Injury or Poisoning
|
- 249. Longitudinal
- [Running lengthwise. ( NCI )] (UMLS (NCI) C0205127) =Spatial Concept
| - 299. LOSS CONT MV-ANIM RIDER
- [ ] (UMLS (ICD9CM) C0261097) =Human-caused Phenomenon or Process
|
- 250. longitudinal animal study
- [studies following a population of animals over a period of time; it includes retrospective studies analyzing characteristics such as dietary and health habits, disease history, environment, and other factors culminating in present health status. ( CSP )] (UMLS (CSP) C0596859) =Intellectual Product =animal population study;
| - 300. LOSS CONTROL MV ACC-DRIV
- [ ] (UMLS (ICD9CM) C0261092) =Human-caused Phenomenon or Process
|
home 
Armenian-English 
top